Biogen Inc. Price Today
Biogen Inc.
BIIB
Healthcare
$29.79B
💰
Market Cap
25.7
💸
Price to Earnings
$8.0
🎉
EPS
+78
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
20 |
Strong Buy |
10 |
Hold |
12 |
Sell |
0 |
Strong Sell |
0 |
BIIB Price Forecast Target
204.9 👉 500.0 +144%
BIIB EPS Forecast
8.0 👉 17.6 +121%
Financials
Profit Margin
12 %
Revenue Growth
-6.2 %
Dividend
$ 0
Held Percent
0.7% - Insiders
93.0% - Institutions
6.3% - Public
Major Fund Holders
-
💰 Primecap Management Company $3.3B
-
💰 Vanguard Group Inc $3.0B
-
💰 Blackrock Inc. $2.9B
-
💰 State Street Corporation $1.4B
-
💰 T. Rowe Price Investment Management, Inc. $1.1B
Stock Ideas
Paul Tudor Jones Portfolio
Paul Tudor Jones is a pioneer in macro trading and founder of Tudor Investment Corporation, one of the earliest pioneering hedge funds. With over 40 years of experience investing across global markets, Jones strategically allocates capital based on …
Nancy Pelosi Portfolio
Nancy Pelosi is the Speaker of the United States House of Representatives and a savvy investor. Her personal portfolio is heavily weighted towards large-cap tech stocks, such as Apple and Microsoft. She also owns shares in several consumer staples a…
Seth Klarman Portfolio
Seth Klarman's investment prowess is exemplified by his exceptional track record. Since the inception of his fund until 2008, he achieved an impressive compound return-on-investment of 20%. This remarkable achievement showcases his astute investment…
Warren Buffet Portfolio
Invest like the oracle himself! View the stocks that Warren Buffett holds in the Berkshire Hathaway portfolio.📮FAQ
Some Frequently Asked Questions.
The Biogen Inc. industry is Drug Manufacturers - General
The Biogen Inc. sector is Healthcare
The Biogen Inc. forecasted predicted Price to Earnings PE ratio is 11.6
The Biogen Inc. Price to Earnings PE ratio is 25.7
The Market Capitalization of Biogen Inc. is $29.79B
There are total of 144811334 float shares with 93.0% held by Institutions and 0.7% held by insiders
The MBiogen Inc. forecasted Earnings per Share EPS is $17.6
The Biogen Inc. Earnings per Share EPS is 8.0
The Biogen Inc. company has $0 gross profits with 12 profit margins
The Biogen Inc. Earnings Growth is -0.549% with -0.546% quarterly earnings growth
The Biogen Inc. Revenue is $9835599872 with -0.062 revenue growth
The price target for Biogen Inc. stock is $500.0 for the high target and $215.0 for the low target
The consensus analyst recommendations for Biogen Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Biogen Inc. is Buy, with the following breakdown:
- Buy: 20
- Strong Buy: 10
- Hold: 12
- Sell: 0
- Strong Sell: 0
The Beta of Biogen Inc. is -0.0
The dividend of Biogen Inc. is $0
The dividend yield of Biogen Inc. is 0%
The biggest institutional and mutual fund holders of Biogen Inc. stock are
- Primecap Management Company
- Vanguard Group Inc
- Blackrock Inc.
- State Street Corporation
The Biogen Inc. ESG Score is 78, with the following breakdown:
- E: 0.42
- S: 14.46
- G: 7.37